$104 Million
Joint Bookrunner
Follow-On
February 2013
$70 Million
Sole Bookrunner
Initial Public Offering
January 2013
$83 Million
Exclusive Financial Advisor
Sale to Analogic Corporation
January 2013
Not Disclosed
Exclusive Financial Advisor
Sale of fiXate Tissue Band Assets to Boston Scientific
January 2013
$34 Million
Joint Bookrunner
Follow-On
January 2013
Not Disclosed
Exclusive Financial Advisor
Strategic Investment From Merck Global Health Innovation
December 2012
Not Disclosed
Financial Advisor
Strategic Investment From GE Healthymagination
December 2012
$115M + Option to Purchase
Exclusive Financial Advisor
Collaboration with BMS for Recothrom Bristol-Myers Squibb
December 2012
$185M + Und. Earnout
Exclusive Financial Advisor
Sale to The Medicines Company
December 2012
$50 Million
Financial Advisor
Royalty Financing Agreement with HealthCare Royalty Partners
December 2012
Not Disclosed
Financial Advisor
Sale to KCI
November 2012
$230 Million
Exclusive Financial Advisor
Sale to Sun Pharmaceutical Industries
November 2012